OPTIFAST® VLCD™ must be taken under the supervision of a healthcare professional such as a Pharmacist, Doctor, Specialist or Accredited Practicing Dietitian. Research has shown that having the support and guidance of a healthcare professional will make the program more successful. As a healthcare professional, you can tailor the plan to suit your patients’ specific likes and dislikes, medical conditions, nutritional needs, physical activity levels and lifestyle. If your patient has a co-existing medical condition then you may need to monitor them more closely or even adjust their medication dosage.
It is recommended that once a patient has commenced on the Intensive phase of the OPTIFAST® VLCD™ Program they should be followed up fortnightly for check-ups, weight and waist circumference monitoring, advice and encouragement.
Patients can be classified as low medical risk, or high medical risk when following a VLCD. For all patients, regular monitoring of weight, BMI, waist circumference and blood pressure is recommended during the Intensive phase of the OPTIFAST® VLCD™ Program. Regular blood monitoring is important during the Intensive phase of the OPTIFAST® VLCD™ Program for ‘high risk’ patients because of the risk of electrolyte imbalance.
|High Medical Risk Patient||Low Medical Risk Patient|
|BMI>27 plus co-morbidities||No co-morbidities|
|Taking prescribed medications during the VLED||No prescription medications|
|Greater than 65 years of age||Less than 65 years of age|
|Assessment||Baseline Measures||6 weeks||Completion of Intensive Phase|
|Electrolytes/ Creatinine||#yes||If required||#yes|
|Liver function tests||#yes||If required||#yes|
|Fasting Glucose||#yes||If required||#yes|
|Cholesterol/ Triglycerides/ HDL||#yes||If required||#yes|
|Uric acid||#yes||If required||#yes|
|Full Blood Count||#yes||If required||#yes|
|Iron Studies||#yes||If required||#yes|
|Vitamin D||#yes||If required||#yes|
|Calcium & Parathyroid (in patients on long term anticonvulsants)||#yes||If required||#yes|